Recurrence dynamics does not depend on the recurrence site

Breast Cancer Research

Volumn 10, Issue 5, 2008, Pages

  Demicheli, Romano ^a   Biganzoli, Elia ^a,b   Boracchi, Patrizia ^b   Greco, Marco ^a   Retsky, Michael W ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; ITALY; LIFE TABLE; METASTASIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; SECOND CANCER; TUMOR RECURRENCE; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LIFE TABLES; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; ORGAN SPECIFICITY; PROPORTIONAL HAZARDS MODELS;

EID: 59449094924     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2152     Document Type: Article

References (31)

1. Demicheli R, Valagussa P, Foroni R, Bonadonna G. Mean relapse rate per year (MRR/Y) suggests different biological conditions of breast cancer micrometastases at the time of primary local-regional treatment. Proc Am Soc Clin Oncol 1993, 12:119.
2. Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumour dormancy. Breast Cancer Res. Treat 1996, 41:177-185. 10.1007/BF01807163, 8944336.
3. Demicheli R, Bonadonna G, Hrushesky WJM, Retsky MW, Valagussa P. Menopausal status dependence of the timing of breast cancer recurrence following primary tumour surgical removal. Breast Cancer Res 2004, 6:R689-696. 1064084, 15535851, 10.1186/bcr937.
4. Baum M, Badwe RA. Does surgery influence the natural history of breast cancer?. Breast Cancer: Controversies in Management 1994, 61-69. Armonk, NY: Futura Publishing Company Inc, Johnson H Jr.
5. Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999, 17:101-109.
6. Gasparini G, Biganzoli E, Bonoldi E, Morabito A, Fanelli M, Boracchi P. Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapy. Breast Cancer Res Treat 2001, 65:71-75. 10.1023/A:1006476401801, 11245342.
7. Jatoi I, Tsimelzon A, Weiss H, Clark GM, Hilsenbeck SG. Hazard rates of recurrence following diagnosis of primary breast cancer. Breast Cancer Res Treat 2005, 89:173-178. 10.1007/s10549-004-1722-0, 15692760.
8. Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJ, Retsky MW, Valagussa P, Bonadonna G. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumour dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol 2005, 16:1449-1457. 10.1093/annonc/mdi280, 15956037.
9. Jerez JM, Franci L, Alba E, Llombart-Cussiac A, Lluch A, Ribelles N, Munarriz B, Martin M. Improvements of breast cancer prediction in high risk intervals using artificial neural networks. Breast Cancer Res Treat 2005, 94:265-272. 10.1007/s10549-005-9013-y, 16254686.
10. Sant M, Gatta G, Micheli A, Verdecchia A, Capocaccia R, Crosignani P, Berrino F. Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer 1991, 27:981-984.
11. Karrison TG, Ferguson DJ, Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 1999, 91:80-85. 10.1093/jnci/91.1.80, 9890174.
12. Yakovlev AY, Tsodikov AD, Boucher K, Kerber R. The shape of the hazard function in breast carcinoma: curability of the disease revisited. Cancer 1999, 85:1789-1798. 10.1002/(SICI)1097-0142(19990415)85:8<1789::AID-CNCR20>3.0.CO;2-Q, 10223574.
13. Gao F, Tan SB, Machin D, Wong NS. Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study. Breast Cancer Res 2007, 9:R21. 1868926, 17341292, 10.1186/bcr1658.
14. Demicheli R, Retsky MW, Swartzendruber DE, Bonadonna G. Proposal for a new model of breast cancer metastatic development. Ann Oncol 1997, 8:1075-1080. 10.1023/A:1008263116022, 9426326.
15. Retsky MW, Demicheli R, Swartzendruber DE, Bame PD, Wardwell RH, Bonadonna G, Speer JF, Valagussa P. Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat 1997, 45:193-202. 10.1023/A:1005849301420, 9342444.
16. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981, 305:6-11.
17. Kamby C, Rose C, Ejlertsen B, Andersen J, Birkler NE, Rytter L, Andersen KW, Zedeler K. Stage and pattern of metastases in patients with breast cancer. Eur J Cancer Clin Oncol 1987, 23:1925-1934. 10.1016/0277-5379(87)90061-7, 3436355.
18. Ramlau-Hansen H. Smoothing counting process intensities by means of Kernel functions. Ann Statistics 1983, 11:453-466.
19. Boracchi P, Biganzoli E, Marubini E. Joint modelling of cause specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Comput Statist Data Anal 2003, 42:243-262.
20. Gray RJ. Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis. J Amer Statist Assoc 1992, 87:942-951.
21. Dawson PJ, Maloney T, Gimotty P, Juneau P, Ownby H, Wolman SR. Bilateral breast cancer: one disease or two?. Breast Cancer Res Treat 1991, 19:233-244. 10.1007/BF01961160, 1663803.
22. Broet P, de la Rochefordiere A, Scholl SM, Fourquet A, Mosseri M, Durand JC, Pouillart P, Asselain B. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 1995, 13:1578-1583.
23. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerham L, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, Russel I. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985, 312:665-673.
24. Recht A, Silen W, Connolly J, Gelman RS, Rose MA, Silver B, Harris JR. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys 1988, 15:255-261. 10.1016/S0360-3016(98)90002-5, 2841261.
25. Hafty BG, Fisher D, Beinfield M, McKhann C. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 1991, 21:293-298.
26. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK. Classifying local disease recurrences after breast conservation therapy based on location and histology. New primary tumours have more favourable outcomes than true local disease recurrences. Cancer 2002, 95:2059-2067. 10.1002/cncr.10952, 12412158.
27. Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 2005, 12:104-111. 10.2325/jbcs.12.104, 15858440.
28. Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumour relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000, 48:1281-1289.
29. Voogd AC, van Oost FJ, Rutgers EJT, Elkhuizen PHM, van Geel AN, Scheijmans LJEE, Sangen MJC, Botke G, Hoekstra CJ, Jobsen JJ, Velde CJH, von Meyenfeldt MF, Tabak JM, Peterse JL, Vijver MJ, Coeberg JWW, van Tienhoven G, . for the Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group) Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 2005, 41:2637-2644. 10.1016/j.ejca.2005.04.040, 16115758, for the Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group).
30. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biologic properties of disseminating tumour cells. Nat Rev Cancer 2008, 8:329-340. 10.1038/nrc2375, 18404148.
31. Husemann Y, Geigl JB, Shubert F, Musiani P, Meyer M, Burghert E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68. 10.1016/j.ccr.2007.12.003, 18167340.